Literature DB >> 17940963

Mapping of a region of Ebola virus VP40 that is important in the production of virus-like particles.

Seiya Yamayoshi1, Yoshihiro Kawaoka.   

Abstract

Ebola virus VP40 contains 2 overlapping late domains (7-PTAP-10 and 10-PPEY-13) that are essential for its interaction with Tsg101 and Nedd4 in the promotion of viral egress. Deletion of the late domains inhibits VP40-induced virus-like particles (VLPs). However, a truncated form of VP40, which lacks a late domain because of the deletion of amino acids 1-30, is released into supernatant as a VLP, indicating that the remaining portion of VP40 contains the structural elements required for VLP release. Thus, the purpose of this study was to identify the VP40 sequence essential for VLP budding, through the generation of deletion and alanine-scanning mutants. We found that the amino acid sequence around the proline at position 53 plays a critical role in VLP production and intracellular transport. These data also may suggest that a novel host factor(s) is involved in virus budding.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17940963     DOI: 10.1086/520595

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  20 in total

1.  Viral and host proteins that modulate filovirus budding.

Authors:  Yuliang Liu; Ronald N Harty
Journal:  Future Virol       Date:  2010-07-01       Impact factor: 1.831

2.  Predictive and comparative analysis of Ebolavirus proteins.

Authors:  Qian Cong; Jimin Pei; Nick V Grishin
Journal:  Cell Cycle       Date:  2015-07-09       Impact factor: 4.534

3.  Identification of amino acids in Marburg virus VP40 that are important for virus-like particle budding.

Authors:  Akiko Makino; Seiya Yamayoshi; Kyoko Shinya; Takeshi Noda; Yoshihiro Kawaoka
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

Review 4.  Advances in virus-like particle vaccines for filoviruses.

Authors:  Kelly L Warfield; M Javad Aman
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

5.  Interdomain salt-bridges in the Ebola virus protein VP40 and their role in domain association and plasma membrane localization.

Authors:  Jeevan B Gc; Kristen A Johnson; Monica L Husby; Cary T Frick; Bernard S Gerstman; Robert V Stahelin; Prem P Chapagain
Journal:  Protein Sci       Date:  2016-07-04       Impact factor: 6.725

6.  Longitudinal Human Antibody Repertoire against Complete Viral Proteome from Ebola Virus Survivor Reveals Protective Sites for Vaccine Design.

Authors:  Surender Khurana; Supriya Ravichandran; Megan Hahn; Elizabeth M Coyle; Spencer W Stonier; Samantha E Zak; Jason Kindrachuk; Richard T Davey; John M Dye; Daniel S Chertow
Journal:  Cell Host Microbe       Date:  2020-02-12       Impact factor: 21.023

7.  The multifunctional Ebola virus VP40 matrix protein is a promising therapeutic target.

Authors:  Jonathan J Madara; Ziying Han; Gordon Ruthel; Bruce D Freedman; Ronald N Harty
Journal:  Future Virol       Date:  2015-05       Impact factor: 1.831

8.  Ebola virus-like particles stimulate type I interferons and proinflammatory cytokine expression through the toll-like receptor and interferon signaling pathways.

Authors:  Natarajan Ayithan; Steven B Bradfute; Scott M Anthony; Kelly S Stuthman; John M Dye; Sina Bavari; Mike Bray; Keiko Ozato
Journal:  J Interferon Cytokine Res       Date:  2013-10-08       Impact factor: 2.607

Review 9.  No exit: targeting the budding process to inhibit filovirus replication.

Authors:  Ronald N Harty
Journal:  Antiviral Res       Date:  2008-12-27       Impact factor: 5.970

10.  Role of the GTPase Rab1b in ebolavirus particle formation.

Authors:  Seiya Yamayoshi; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2010-02-17       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.